High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.
about
Quantification of liver fat in the presence of iron overload.Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should doNonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health StudyUsing an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.Statin Effects to Reduce Hepatosteatosis as Measured by Computed Tomography in Patients With Human Immunodeficiency VirusCardiac CT angiography for evaluation of acute chest pain.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Inferior vena cava segmentation with parameter propagation and graph cut.Research update for articles published in EJCI in 2013.The prognostic value of CT coronary angiography in patients attending hospital with troponin-negative acute chest pain and inconclusive exercise treadmill tests.The association of hemoglobin A1c and high risk plaque and plaque extent assessed by coronary computed tomography angiography.Epicardial and paracardial adipose tissue volume and attenuation - Association with high-risk coronary plaque on computed tomographic angiography in the ROMICAT II trial.Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.Rationale, Design, and Methodological Aspects of the BUDAPEST-GLOBAL Study (Burden of Atherosclerotic Plaques Study in Twins-Genetic Loci and the Burden of Atherosclerotic Lesions).CAD-RADS - a new clinical decision support tool for coronary computed tomography angiography.Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.New insights into NAFLD and Subclinical Coronary Atherosclerosis.Relationship of hepatic steatosis severity and coronary artery disease characteristics assessed by coronary CT angiography.MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD).Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects
P2860
Q33645229-BD9213CE-67EE-4540-A5CB-BC5AB631E199Q33716191-5340DD5A-579D-4DF1-889B-012B42C5D453Q35678746-526FBD12-F387-4CDB-B5FF-364B804A0131Q35848217-3A9FE398-B44A-49EB-81E0-0972D38A8CE6Q36892592-C2BF3115-CAB3-4D42-8DA9-ECC06BCECAB1Q37091619-D55AC829-A349-4F9E-AA2E-3B1BCA1CAAB8Q38581423-38A996A7-F519-4B73-9B57-F0A071D78A79Q38711424-376FA366-FCA1-46DC-B661-066063FBC13BQ38728576-A9A64431-4365-485F-AC17-FABCD7ED9A09Q38852737-C10C8581-F313-4528-AFBA-6247BE4BA25CQ38927965-C50F15F5-05E3-495D-841E-B5B9176E051CQ38953879-8B02115B-307A-46A1-ADAC-8223F914F5E0Q42359819-6470E696-A563-42B4-AB0E-0309F490186AQ44087796-E2B36AC9-90BF-45D0-B018-86F2A7201DACQ45021024-F5982B18-4E1D-4FF1-801F-000C66CBC8DFQ47633261-56BAE79D-F1EF-46D6-94E9-B6358FB1F5C6Q49501260-80AC7FBF-3F5A-4545-9AF3-DFEC8877E844Q50148682-1DAC4AF7-C263-4B32-A0C2-BA80BFB7293EQ52985248-88652849-88DC-400D-A786-7F0CE3CB9BAAQ55060289-442FCD13-A4CD-4505-BC3B-5CDF2F233CFFQ58722876-2E806518-BB3D-4786-82EB-00914930ED7E
P2860
High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
High-risk coronary plaque at c ...... lts from the ROMICAT II trial.
@ast
High-risk coronary plaque at c ...... lts from the ROMICAT II trial.
@en
type
label
High-risk coronary plaque at c ...... lts from the ROMICAT II trial.
@ast
High-risk coronary plaque at c ...... lts from the ROMICAT II trial.
@en
prefLabel
High-risk coronary plaque at c ...... lts from the ROMICAT II trial.
@ast
High-risk coronary plaque at c ...... lts from the ROMICAT II trial.
@en
P2093
P2860
P356
P1433
P1476
High-risk coronary plaque at c ...... lts from the ROMICAT II trial.
@en
P2093
Amit Pursnani
Brian B Ghoshhajra
Jerome L Fleg
Maros Ferencik
Michael T Lu
Quynh A Truong
Stefan B Puchner
Stephen D Wiviott
Thomas Mayrhofer
P2860
P304
P356
10.1148/RADIOL.14140933
P407
P50
P577
2014-11-04T00:00:00Z